Bausch + Lomb-sponsored first annual visionary report sheds light on nation’s ‘blind spots’ on age-related macular degeneration, a leading cause of vision loss in people over 50


New Report Finds Vision Loss a Concern for Aging Americans Surveyed, But Majority Unaware Age-Related Macular Degeneration Is a Leading Cause of Blindness

VAUGHAN, Ontario, September 13, 2022 /PRNewswire/ — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better , today released a report on the results of a survey conducted by the company’s first annual Visionary reportwhich was designed to identify key new insights into the value Americans place on their eyesight, as well as the “blind spots” that may exist in understanding and awareness of age-related macular degeneration ( AMD), one of the main causes of vision loss for people over 501 and the leading cause of blindness for the population aged 65 and over2.

Check out the full interactive multi-channel press release here: https://www.multivu.com/players/English/8949451-bausch-lomb-sponsored-visionary-report-amd/

Specifically in the report, 81% of American adults surveyed would be willing to give up something else that is important – going on vacation, a million dollars, the internet, listening to music, the ability to remember names of people or another of their senses – if that meant never losing your sight. Despite this clear prioritization of the ability to see, only 37% of American adults over 50 surveyed know that AMD is a very real threat as the leading cause of vision loss for Americans.

“Today in United Statesapproximately 16 million Americans suffer from AMD, and this figure is expected to increase as the number of people aged 65 and over continues to increase,”3-4 said Joe Gordon, President, Global Consumer, Surgical and Vision Care, Bausch + Lomb. “Bausch + Lomb is committed to meeting the eye health needs of patients, and we believe it is important to better understand how Americans understand this disease and its potentially debilitating impact on their vision. We hope this report will raise awareness, help fill these education gaps and foster an important dialogue between eye care professionals and their patients.”

Main results of 2022 Visionary report to understand:

Sight is a crystal clear priority across generations.

  • 62% of Americans over 50 fear losing their sight as they age.
  • 81% of Americans would give up any of the following if it meant never losing their sight: going on vacation, a million dollars, the Internet, listening to music, the ability to remember people’s names or another of their senses.

Despite this, AMD, one of the main causes of vision loss, is not the main concern.

  • Only 44% of Americans are concerned about developing AMD as they age.
  • Impact of Alzheimer’s disease and dementia 11% seniors aged 65 and over and 82% of Americans aged 65 and over are very/fairly familiar with it. On the other hand, AMD impacts 30% of the population aged 65 and over and only 56% people over 65 are aware of this.5

AMD’s true understanding remains unclear.

  • 61% of Americans don’t know that a dilation eye exam is necessary to diagnose AMD.
  • 58% of Americans over 50 don’t know if AMD progression is inevitable.
  • less than half of Americans know that vitamins/supplements can reduce the risk of AMD progression in some patients.

Americans want to see what they missed, learn more, and take action.

  • 75% of Americans who see an ophthalmologist/optometrist and have heard of AMD have never discussed it with their provider.
  • 77% of this group would be interested in discussing AMD, along with its warning signs and risk factors, with their ophthalmologist.

“The data included in the Bausch + Lomb Visionary report is impactful as a practicing physician as it demonstrates that many of those who are vulnerable to AMD are unaware of the risk and unfortunately do not fully understand AMD and how it can affect their vision,” said Rishi Singh, staff physician, Cleveland Clinic Florida, and president, Cleveland Clinic Martin North and South Hospitals. “It is clear that the majority of Americans who have seen an eye doctor want to discuss the disease, warning signs and risk factors, and this is information that my colleagues and I can use to help patients feel confident and in control of their eye health.

To read the 2022 Visionary Report, visit https://www.sightmatters.com/visionary-report.

About the methodology behind the Visionary report
The Visionary report was conducted online in United States by The Harris Poll on behalf of Bausch + Lomb of April 14-18, 2022 among 2,073 respondents, aged 18 and over. The sampling precision of Harris online polls is measured using a Bayesian credibility interval. For this study, the sample data is accurate to within +2.8 percentage points using a 95% confidence level.

About AMD
Age-related macular degeneration (AMD) is a progressive eye condition that affects central vision and is a leading cause of blindness in adults aged 50 and over. The eye disease affects central vision and occurs when the macula – the part of the eye that controls sharp direct vision – is damaged over time, making people having difficulty seeing faces, reading, driving or doing close work such as cooking.3 Early-stage AMD often has no symptoms or changes in vision, as symptoms usually appear gradually over time. This progressive condition can affect one or both eyes.3

About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every stage of life. Its comprehensive portfolio of over 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and sales footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with headquarters in Bridgewater, New Jersey. For more information, visit www.bausch.com and contact us at TwitterLinkedIn, Facebook and Instagram.

Forward-looking statements
This press release may contain forward-looking statements, which can generally be identified by the use of the words “anticipates”, “hopes”, “expects”, “intends”, “expects”, “should ‘, ‘could’, ‘would’, ‘may’, ‘believes’, ‘estimates’, ‘potential’, ‘target’ or ‘continues’ and similar variations or expressions. These statements are based on management’s current expectations and beliefs and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb’s filings with the United States Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated into present by reference. They also include, but are not limited to, the risks and uncertainties caused by or related to the evolution of the COVID-19 pandemic, as well as the fear of this pandemic and its potential effects, including the severity, duration and future impact are highly uncertain and cannot be predicted, and which could have a material adverse impact on Bausch + Lomb, including, but not limited to, delays in its project development, launches and costs (which may increase). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual results, except as required by law.

References

  1. Source: Prevent Blindness: Age-Related Macular Degeneration Fact Sheet: https://preventblindness.org/wp-content/uploads/2021/01/PBAMD_Fact-Sheet21.pdf.
  2. Centers for Disease Control and Prevention website. Retrieved from https://www.cdc.gov/visionhealth/resources/features/macular-degeneration.html#:~:text=AMD%20is%20a%20major%20cause,vision%20needed%20to%20see%20clearly. Accessed June 8, 2022.
  3. National Eye Institute website. Retrieved from https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration. Accessed June 8, 2022.
  4. United States Census Bureau, population projections. Retrieved from https://www.census.gov/newsroom/press-releases/2018/cb18-41-population-projections.html. Accessed June 8, 2022.
  5. Centers for Medicare and Medicaid Services, State/County Chronic Condition Prevalence Table: All Fee-for-Service Beneficiaries.

© 2022 Bausch & Lomb Incorporated or its affiliates.
PV2.0092.USA.22

SOURCE Bausch + Lomb

Previous Industry Outlook, Market Entry Strategies, Competitive Landscape
Next A mother of three shares her CAR T-cell therapy journey